Volume 81, Issue 12, Pages (June 2012)

Slides:

Advertisements

Similar presentations

Volume 82, Issue 12, Pages (December 2012)

Advertisements

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto

Vitamin D levels and patient outcome in chronic kidney disease

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Volume 94, Issue 3, Pages (September 2018)

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient Christoph Wanner,

Volume 74, Pages S1-S3 (August 2008)

Sumeska Thavarajah, MD, Daphne H. Knicely, MD, Michael J. Choi, MD

Viper venom for diabetic nephropathy

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Volume 83, Issue 3, Pages (March 2013)

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

NSAID Use and Progression of Chronic Kidney Disease

Volume 79, Issue 12, Pages (June 2011)

Rajiv Agarwal, John W. Kusek, Maria K. Pappas Kidney International

Viper venom for diabetic nephropathy

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets David M. Spiegel, Kate Brady Kidney.

Chronic Kidney Disease in Diabetes

Prehypertension and chronic kidney disease: the ox or the plow?

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

Volume 82, Issue 12, Pages (December 2012)

Rise or fall of glomerular filtration rate: does it matter?

Volume 78, Issue 8, Pages (October 2010)

Nat. Rev. Cardiol. doi: /nrcardio

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

End-stage renal disease in living kidney donors

Volume 77, Issue 1, Pages 5-6 (January 2010)

Volume 84, Issue 1, Pages (July 2013)

Steven J. Rosansky, Richard J. Glassock Kidney International

Volume 74, Issue 3, Pages (August 2008)

Volume 82, Issue 3, Pages (August 2012)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

U-shaped effect of eGFR and mortality

Volume 76, Issue 10, Pages (November 2009)

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.

Volume 69, Issue 12, Pages (June 2006)

Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target? Hatem Amer, Matthew D. Griffin Kidney International

Volume 73, Issue 12, Pages (June 2008)

Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen David I. Ortiz-Melo, Robert F. Spurney

Volume 72, Issue 12, Pages (December 2007)

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto

Vitamin D levels and patient outcome in chronic kidney disease

Volume 69, Issue 12, Pages (June 2006)

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

Methods for guideline development

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 76, Issue 8, Pages (October 2009)

Nephrology Crossword: Glomerulonephritis

Volume 75, Issue 5, Pages (March 2009)

Volume 85, Issue 5, Pages (May 2014)

Volume 80, Issue 3, Pages (August 2011)

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

Volume 80, Issue 12, Pages (December 2011)

Cardio-Kidney-Damage: a unifying concept

Volume 81, Issue 7, Pages (April 2012)

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 73, Issue 5, Pages (March 2008)

Blood lead and chronic kidney disease in the general United States population: Results from NHANES III Paul Muntner, Jiang He, Suma Vupputuri, Josef.

Volume 80, Issue 10, Pages (November 2011)

Volume 81, Issue 7, Pages (April 2012)

Volume 85, Issue 6, Pages (June 2014)

Volume 74, Issue 3, Pages (August 2008)

Adiponectin: good, bad, or just plain ugly?

Volume 81, Issue 11, Pages (June 2012)

Friends, social networks, and progressive chronic kidney disease

Proteinuria and hypertension with tyrosine kinase inhibitors

Effect of methylprednisolone versus placebo on the risk of acute kidney injury: subgroup analysis by preoperative chronic kidney disease. Effect of methylprednisolone.

Sumeska Thavarajah, MD, Daphne H. Knicely, MD, Michael J. Choi, MD

Presentation transcript:

Volume 81, Issue 12, Pages 1248-1253 (June 2012) Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD Arsh K. Jain, Meaghan S. Cuerden, Ian McLeod, Brenda Hemmelgarn, Ayub Akbari, Marcello Tonelli, Rob R. Quinn, Matt J. Oliver, Amit X. Garg Kidney International Volume 81, Issue 12, Pages 1248-1253 (June 2012) DOI: 10.1038/ki.2012.18 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Age- and sex-standardized rate of RAAS-blocker use. Each bar represents a 4-month interval. The solid line with 95% confidence intervals represents the forecasted rate of RAAS-blocker use using an autoregressive integrated moving average model. CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; RAAS blocker, renin, angiotensin, aldosterone system blocker. Kidney International 2012 81, 1248-1253DOI: (10.1038/ki.2012.18) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Confirmation of model appropriateness. Residual autocorrelation was not detected using Ljung–Box χ2-test statistics for different lag periods; residual autocorrelation was not detected by visual assessment of standardized residual autocorrelation function plot. ACF, autocorrelation function. Kidney International 2012 81, 1248-1253DOI: (10.1038/ki.2012.18) Copyright © 2012 International Society of Nephrology Terms and Conditions